Hygeia Healthcare Holdings Co., Limited repurchased 214,000 ordinary shares on 05 October 2026 through on-market transactions on the Hong Kong Stock Exchange.
• Price range: HKD 9.245–9.35 per share, with a volume-weighted average of HKD 9.34. • Cash outlay: HKD 1.99 million.
Post-transaction, the company’s issued share capital (excluding treasury shares) fell to 602.22 million, while treasury shares rose to 16.28 million. Total issued shares remain unchanged at 618.50 million. Treasury shares now represent roughly 2.63 % of total issued shares.
The repurchase forms part of the mandate approved on 26 June 2026 that allows Hygeia Health to buy back up to 60.77 million shares. Cumulative repurchases under this mandate stand at 5.52 million shares, equivalent to 9.11 % of the authorised limit and 0.91 % of issued shares at the approval date.
A moratorium on new share issues or treasury-share sales remains in effect until 04 November 2026 in line with Hong Kong listing regulations.